OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of novel anticancer flavonoids as potential HDAC2 inhibitors: virtual screening approach based on molecular docking, DFT and molecular dynamics simulations studies
Ashish Shah, Aarti Choudhary, Manav Jain, et al.
3 Biotech (2024) Vol. 14, Iss. 3
Closed Access | Times Cited: 14
Ashish Shah, Aarti Choudhary, Manav Jain, et al.
3 Biotech (2024) Vol. 14, Iss. 3
Closed Access | Times Cited: 14
Showing 14 citing articles:
Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeutics
Md Nayab Sulaimani, Sayeed Ahmed, Farah Anjum, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0311954-e0311954
Open Access
Md Nayab Sulaimani, Sayeed Ahmed, Farah Anjum, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0311954-e0311954
Open Access
Structure‐based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach
Sirajul Islam, Md. Al Amin, Kannan R. R. Rengasamy, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 2
Sirajul Islam, Md. Al Amin, Kannan R. R. Rengasamy, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 2
Insilico discovery of novel Phosphodiesterase 4 (PDE4) inhibitors for the treatment of psoriasis: Insights from computer aided drug design approaches
Abdullah R. Alanzi, Mohammed S. Alsalhi, Ramzi A. Mothana, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0305934-e0305934
Open Access | Times Cited: 1
Abdullah R. Alanzi, Mohammed S. Alsalhi, Ramzi A. Mothana, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0305934-e0305934
Open Access | Times Cited: 1
Exploring the conformational dynamics and key amino acids in the CD26-caveolin-1 interaction and potential therapeutic interventions
Xiaopeng Hu, Chunmei Jiang, Yanli Gu, et al.
Medicine (2024) Vol. 103, Iss. 22, pp. e38367-e38367
Open Access
Xiaopeng Hu, Chunmei Jiang, Yanli Gu, et al.
Medicine (2024) Vol. 103, Iss. 22, pp. e38367-e38367
Open Access
Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B
Saba Noor, Arunabh Choudhury, Khursheed Ul Islam, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access
Saba Noor, Arunabh Choudhury, Khursheed Ul Islam, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access
Naturally Occurring Plant‐Based Anticancerous Candidates as Potential ERK2 Inhibitors: In‐Silico Database Mining and Molecular Dynamics Simulations
Mahmoud A. A. Ibrahim, Sara S. M. Ali, Alaa H. M. Abdelrahman, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access
Mahmoud A. A. Ibrahim, Sara S. M. Ali, Alaa H. M. Abdelrahman, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access
In silico exploration of PD-L1 binding compounds: Structure-based virtual screening, molecular docking, and MD simulation
Abdullah R. Alanzi, Ashaimaa Y. Moussa, Ramzi A. Mothana, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0306804-e0306804
Open Access
Abdullah R. Alanzi, Ashaimaa Y. Moussa, Ramzi A. Mothana, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0306804-e0306804
Open Access
Exploration of alpha-glucosidase inhibitors: A comprehensive in silico approach targeting a large set of triazole derivatives
Oussama Abchır, Meriem Khedraoui, Imane Yamari, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308308-e0308308
Open Access
Oussama Abchır, Meriem Khedraoui, Imane Yamari, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308308-e0308308
Open Access
Bioactive Compounds from Achyranthes Aspera L. Extract: A UHPLC Profile and In Silico Study for Mouth Cancer
Juveriya Israr, Tanveer Ahamad, Shabroz Alam, et al.
ChemistrySelect (2024) Vol. 9, Iss. 38
Open Access
Juveriya Israr, Tanveer Ahamad, Shabroz Alam, et al.
ChemistrySelect (2024) Vol. 9, Iss. 38
Open Access
Potential MAO‐B Inhibitors from Cissampelos capensis L.f.: ADMET, Molecular Docking, Dynamics, and DFT Insights
Mohammad G. Al‐Thiabat, Mohit Agrawal, Kantrol Kumar Sahu, et al.
Chemistry & Biodiversity (2024)
Open Access
Mohammad G. Al‐Thiabat, Mohit Agrawal, Kantrol Kumar Sahu, et al.
Chemistry & Biodiversity (2024)
Open Access
Elucidating the monoamine oxidase B inhibitory effect of kaurene diterpenoids from Xylopia aethiopica: An in silico approach
Funmilayo Gladys Famuyiwa, Rajesh B. Patil, Samson O. Famuyiwa, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0308021-e0308021
Open Access
Funmilayo Gladys Famuyiwa, Rajesh B. Patil, Samson O. Famuyiwa, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0308021-e0308021
Open Access
Bioactive Small Molecules and Drug Discovery
Ashish S. Shah, Vaishali Patel, Sathiaseelan Perumal, et al.
(2024), pp. 25-48
Closed Access
Ashish S. Shah, Vaishali Patel, Sathiaseelan Perumal, et al.
(2024), pp. 25-48
Closed Access
Causal-inferring and molecular-docking yield new targets for malignant melanoma therapy
Yan Jin, Xia Ding, Chunyuan Xu
Archives of Dermatological Research (2024) Vol. 317, Iss. 1
Closed Access
Yan Jin, Xia Ding, Chunyuan Xu
Archives of Dermatological Research (2024) Vol. 317, Iss. 1
Closed Access
Galangin promotes apoptosis by upregulating the pro-apoptotic gene BAX in triple-negative breast cancer
Shruti Sinnarkar, Poonam Suryawanshi, Ajinkya Dilip, et al.
Journal of the Egyptian National Cancer Institute (2024) Vol. 36, Iss. 1
Open Access
Shruti Sinnarkar, Poonam Suryawanshi, Ajinkya Dilip, et al.
Journal of the Egyptian National Cancer Institute (2024) Vol. 36, Iss. 1
Open Access
